Verano Earnings + Call Notes
U.S. cannabis leader shares Q124 results
$221M Revs; est. $216M
$67M AEBITDA: est. $66M
$113 M GP; est. $108.1M
$22.7 OI; est. $29.5M
51% GM; est. 50.1%
($5M) NI; est. ($16.7M)
“With adult use imminent in Ohio, confirmed on the November ballot in Florida, and on the horizon in Pennsylvania, we have significant opportunities in these core Verano markets where we currently operate nearly 100 retail dispensaries alone. If fully approved, layering on DEA rescheduling would have also enabled us to save an estimated $80 million in tax payments in 2023, allowing us to reinvest back into the business, and take swift action towards listing on a U.S. exchange if permitted.”
Call Notes
Keep reading with a 7-day free trial
Subscribe to Cannabis Confidential to keep reading this post and get 7 days of free access to the full post archives.